Could a vaccine, one day, be given to prevent breast cancer and other forms of the disease? Mayo Clinic surgeon Dr. Amy Degnim is on the team that’s evaluating a vaccine against the her-2 protein found in the majority of women with non-invasive breast cancer, called ductal carcinoma in situ, or DCIS:
She adds that assessing this vaccine in women with DCIS is an important step toward the ultimate goal of eliminating cancer from our world.
Clinical trials at the Mayo Clinic continue and Mayo reports patients continue to show positive result and with AI technology, a vaccine could be available within a couple of years that may not only stop the recurrence of breast and ovarian cancers but also prevent them from developing in the first place.
